Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05472090 |
|---|---|
| Brief Title: | A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection (PREVAIL) |
| First Submitted : | July 21, 2022 |
| First Submitted that Met QC Criteria : | July 21, 2022 |
| First Posted : | July 25, 2022 |
| Last Update Submitted that Met QC Criteria : | September 5, 2023 |
| Last Update Posted : | September 6, 2023 |